NIAID Funding News, February 7, 2018

February 7, 2018 NIAID Funding News Read this full issue online at http://www.niaid.nih.gov/grants-contracts/funding-news-notices Feature Articles  Strengthen Your Application With Preliminary Research Your preliminary research may be the difference between your application's scoring within or short of NIAID's paylines. Opportunities and Resources Small Business Omnibus Solicitations Reissued for FORMS-E, Clinical Trials To accommodate NIH's new clinical trial policies, the small business innovation research and small business technology transfer parent funding opportunity announcements (FOAs) were each split into two separate FOAs, one that accepts clinical trial applications and one that does not. In The News No Clinical Trial-Related Materials Allowed in Appendix Unless otherwise noted in the funding opportunity announcement to which you are applying, you can no longer include clinical trial-related materials in the Appendix of your grant application. Interim Final Rule: Six-Month Delay, For Now The latest revision to the Federal Policy for the Protection of Human Subjects ("Common Rule") will kick in later to allow more time for organizations to implement the requirements and for stakeholders to comment about whether there is need for an additional delay. Advice Corner When and How To Contact a Program Officer Before you email or leave a voicemail for your program officer, ask yourself: Am I certain he or she is the person I need to answer my question or resolve my issue? Reader Questions Do foreign organizations have additional registration steps for electronic applications? What is a select agent or toxin? New Funding Opportunities PAR-18-633, NIAID Clinical Trial Implementation Cooperative Agreement (U01, Clinical Trial Required) PAR-18-632, NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44, Clinical Trial Required) RFP-NIAID-DAIT-NIHAI201700100, Vaccine Adjuvant Discovery Program PAR-18-630, Investigator Initiated Extended Clinical Trial (R01, Clinical Trial Required) PA-18-589, Successor-in-Interest (Type 6, Parent Clinical Trial Optional) PA-18-590, Change of Grantee Organization (Type 7, Parent Clinical Trial Optional) PA-18-591, Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp, Clinical Trial Optional) PA-18-586, Research Supplements to Promote Diversity in Health-Related Research (Admin Supp, Clinical Trial Not Allowed) PA-18-592, Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp, Clinical Trial Not Allowed ) RFA-RM-18-017, Expanding the Human Genome Editing Repertoire (U01, Clinical Trial Not Allowed) See other announcements at Opportunities & Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to rssproject471@gmail.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

Tweet

Postingan terkait:

— Wednesday, February 7, 2018 — Add Comment